CBDistillery Pet CBD Review 2026: Affordable Options for Pet Parents
Affiliate Disclosure: This post contains affiliate links. We may earn a commission if you purchase through our links, at no...
Read moreAffiliate Disclosure: CBDPet.com participates in affiliate programs. We may earn a commission on qualifying purchases. Our editorial opinions are independent.
Petly CBD is a subscription-focused pet CBD brand that emphasizes veterinarian involvement in product development and personalized pet wellness plans. After testing their core products, here is our honest 2026 review.
Petly CBD differentiates itself by offering a personalized approach — asking about your pet’s size, condition, and wellness goals before recommending specific products. Hemp source: US-grown. Extraction: CO2. Spectrum: Broad-spectrum. Testing: Third-party batch testing.
CBD Oil for Dogs: 250mg, 500mg, 1000mg, 2500mg options. Unflavored (MCT carrier). $29.99-$119.99. CBD Oil for Cats: 125mg, 250mg options. Chicken flavor. $19.99-$34.99. CBD Soft Chews: 5mg per chew, peanut butter and banana flavor. $29.99. CBD Hip & Joint Soft Chews: CBD + glucosamine + chondroitin. $34.99.
Palatability: Unflavored MCT base. Accepted by most dogs when mixed into food. Moderate palatability. Onset: Visible relaxation within 35-50 minutes at 1mg/kg dose. Effect: Consistent and reliable at therapeutic doses. No excessive sedation.
CBD Oil 500mg/30mL: $44.99 ($0.090/mg). CBD Oil 1000mg/30mL: $64.99 ($0.065/mg). CBD Oil 2500mg/60mL: $119.99 ($0.048/mg). Subscription pricing reduces costs by 15-20%.
Bottom line: Petly CBD is a solid, well-tested brand with a thoughtful approach to pet wellness. The vet-informed positioning and subscription model provide genuine value. The unflavored oil is the main palatability drawback.
—
These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Always consult your healthcare provider or veterinarian before starting any new supplement.

Interested in finding out more about what’s happening in the world of CBD and Medicinal Cannabis?
Head to CBD World News for the latest scientific research, clinical trials, and business news.
Abstract: Currently, there are no approved pharmacotherapies for addiction to cocaine and other psychostimulant drugs. Several studies have proposed that...
Read moreCredits: Albert Batalla†, Hella Janssen†, Shiral S. Gangadin and Matthijs G. Bossong († These authors contributed equally to this work.)...
Read moreAuthors: Kimberly A. Babson1 & James Sottile 2 & Danielle Morabito1 Publish Date: 27 March 2017 Published by: Springer Science+Business...
Read more